Lobular neoplasia and atypical ductal hyperplasia (ADH) are high-risk breast lesions
associated with an increased risk of breast cancer. Until recently, surgical excision was …

BACKGROUND Approximately 25% of all cases of atypical ductal hyperplasia (ADH)
diagnosed on core biopsy of the breast are associated with ductal carcinoma in situ (DCIS) …

OBJECTIVE. Atypical ductal hyperplasia (ADH), atypical lobular hyperplasia (ALH), and
lobular carcinoma in situ (LCIS) are among high-risk lesions that have been previously …

A core biopsy diagnosis of atypical ductal epithelial hyperplasia is upstaged on follow-up
excisional biopsy (FUEB) to in situ or invasive carcinoma in about 20% of cases, thus …

Background The significance of lobular neoplasia (LN), lobular carcinoma in situ (LCIS) and
atypical lobular hyperplasia (ALH)) found at core needle biopsy (CNB) of the breast remains …

Atypical lobular hyperplasia (ALH) and lobular carcinoma in situ (LCIS) diagnosed in core
needle biopsy (CNB) are generally regarded as risk indicators for developing invasive …

Recent reports suggest that the finding of lobular neoplasia (atypical lobular hyperplasia
[ALH] or lobular carcinoma in situ [LCIS]) in breast core needle biopsy specimens may be …

The management of lobular neoplasia (LN) found on percutaneous core biopsy remains a
clinical dilemma. The purpose of this study was to establish guidelines for the management …

Atypical ductal hyperplasia (ADH), atypical lobular hyperplasia (ALH), and lobular
carcinoma in situ (LCIS) are commonly seen on breast core needle biopsy (CNB). Many …

Atypical ductal hyperplasia (ADH) and lobular carcinoma in situ (LCIS) may be associated
with a relatively high incidence of invasive carcinoma and ductal carcinoma in situ (DCIS) on …